XML 274 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue, operating profit and segment analysis - Summary of analysis by business segment (Details) - GBP (£)
£ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of operating segments          
Revenue £ 9,161 £ 8,553 £ 7,244 £ 7,110 £ 7,874
Adjusted operating profit 3,030 2,683 2,210 £ 2,076 £ 2,491
Risk          
Disclosure of operating segments          
Revenue 3,133 2,909 2,474    
Scientific, technical & medical          
Disclosure of operating segments          
Revenue 3,062 2,909 2,649    
Legal          
Disclosure of operating segments          
Revenue 1,851 1,782 1,587    
Exhibitions          
Disclosure of operating segments          
Revenue 1,115 953 534    
Operating segments          
Disclosure of operating segments          
Revenue 9,161 8,553 7,244    
Adjusted operating profit 3,042 2,712 2,252    
Operating segments | Risk          
Disclosure of operating segments          
Revenue 3,133 2,909 2,474    
Adjusted operating profit 1,165 1,078 915    
Operating segments | Scientific, technical & medical          
Disclosure of operating segments          
Revenue 3,062 2,909 2,649    
Adjusted operating profit 1,165 1,100 1,001    
Operating segments | Legal          
Disclosure of operating segments          
Revenue 1,851 1,782 1,587    
Adjusted operating profit 393 372 326    
Operating segments | Exhibitions          
Disclosure of operating segments          
Revenue 1,115 953 534    
Adjusted operating profit 319 162 10    
Unallocated central costs and other operating items          
Disclosure of operating segments          
Adjusted operating profit £ (12) (29) (42)    
Charge related to STM, incurred from exchange rate movements from translation of working capital items and outcome of hedging program   £ 24      
One-off charge related to reduction in the corporate real estate footprint     £ 35